{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T12:11:43Z","timestamp":1775995903673,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.humpath.2021.11.001","type":"journal-article","created":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T10:40:01Z","timestamp":1636454401000},"page":"59-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Mantle cell lymphoma with chronic lymphocytic leukemia-like features: a diagnostic mimic and pitfall"],"prefix":"10.1016","volume":"119","author":[{"given":"Lianqun","family":"Qiu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guilin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sa A.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi Young","family":"Ok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophia","family":"Garces","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Cameron","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahsa","family":"Khanlari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Vega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6857-0523","authenticated-orcid":false,"given":"Shaoying","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2021.11.001_bib1","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2021.11.001_bib2","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/bjh.14241","article-title":"15-year follow-up of the Second Nordic Mantle Cell Lymphoma trial (MCL2): prolonged remissions without survival plateau","volume":"175","author":"Eskelund","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2021.11.001_bib3","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1182\/blood.2020005289","article-title":"Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes","volume":"136","author":"Nadeu","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2021.11.001_bib4","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00428-015-1840-6","article-title":"Mantle cell lymphoma--a spectrum from indolent to aggressive disease","volume":"468","author":"Sander","year":"2016","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2021.11.001_bib5","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.3324\/haematol.2010.036277","article-title":"Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis","volume":"96","author":"Ondrejka","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.humpath.2021.11.001_bib6","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1182\/blood-2017-10-764373","article-title":"Chronic lymphocytic leukemia and mantle cell lymphoma: crossroads of genetic and microenvironment interactions","volume":"131","author":"Puente","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2021.11.001_bib7","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1097\/PAS.0000000000001278","article-title":"CD5-negative mantle cell lymphoma: clinicopathologic correlations and outcome in 58 patients","volume":"43","author":"Miao","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2021.11.001_bib8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.humpath.2019.04.010","article-title":"CD23 expression in mantle cell lymphoma is associated with CD200 expression, leukemic non-nodal form, and a better prognosis","volume":"89","author":"Saksena","year":"2019","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2021.11.001_bib9","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/modpathol.2017.135","article-title":"CD200 expression in mantle cell lymphoma identifies a unique subgroup of patients with frequent IGHV mutations, absence of SOX11 expression, and an indolent clinical course","volume":"31","author":"Hu","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2021.11.001_bib10","doi-asserted-by":"crossref","first-page":"11441","DOI":"10.18632\/oncotarget.23571","article-title":"CD10-positive mantle cell lymphoma: clinicopathologic and prognostic study of 30 cases","volume":"9","author":"Xu","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.humpath.2021.11.001_bib11","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1097\/PAS.0000000000001233","article-title":"SOX11-negative mantle cell lymphoma: clinicopathologic and prognostic features of 75 patients","volume":"43","author":"Xu","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2021.11.001_bib12","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/01.pas.0000128671.92609.af","article-title":"Aberrant Bcl6 protein expression in mantle cell lymphoma","volume":"28","author":"Camacho","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2021.11.001_bib13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.anndiagpath.2016.09.016","article-title":"Expression of LEF1 in mantle cell lymphoma","volume":"26","author":"O'Malley","year":"2017","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.humpath.2021.11.001_bib14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11864-019-0684-8","article-title":"Leukemic non-nodal mantle cell lymphoma: diagnosis and treatment","volume":"20","author":"Jain","year":"2019","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.humpath.2021.11.001_bib15","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/modpathol.2015.66","article-title":"Clinical significance of newly emerged isolated del(20q) in patients following cytotoxic therapies","volume":"28","author":"Yin","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2021.11.001_bib16","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/bjh.15877","article-title":"Routine sequencing in CLL has prognostic implications and provides new insight into pathogenesis and targeted treatments","volume":"185","author":"Hu","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2021.11.001_bib17","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1158\/0008-5472.CAN-09-3419","article-title":"Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma","volume":"70","author":"Fernandez","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2021.11.001_bib18","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/MOH.0000000000000434","article-title":"SOX11, a key oncogenic factor in mantle cell lymphoma","volume":"25","author":"Beekman","year":"2018","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.humpath.2021.11.001_bib19","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/his.13935","article-title":"Increased tumour angiogenesis in SOX11-positive mantle cell lymphoma","volume":"75","author":"Petrakis","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2021.11.001_bib20","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1182\/blood-2012-06-438937","article-title":"SOX11 regulates\u00a0PAX5 expression and blocks terminal B-cell differentiation in aggressive mantle cell lymphoma","volume":"121","author":"Vegliante","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2021.11.001_bib21","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1038\/leu.2015.355","article-title":"SOX11 defines two different subtypes of mantle cell lymphoma through transcriptional regulation of BCL6","volume":"30","author":"Palomero","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2021.11.001_bib22","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/PAS.0b013e3182a43996","article-title":"Assessment of SOX11 expression in routine lymphoma tissue sections: characterization of new monoclonal antibodies for diagnosis of mantle cell lymphoma","volume":"38","author":"Soldini","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2021.11.001_bib23","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.hoc.2020.05.002","article-title":"Molecular pathogenesis of mantle cell lymphoma","volume":"34","author":"Navarro","year":"2020","journal-title":"Hematol Oncol Clin N Am"},{"key":"10.1016\/j.humpath.2021.11.001_bib24","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.1158\/0008-5472.CAN-12-1615","article-title":"Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical features","volume":"72","author":"Navarro","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2021.11.001_bib25","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.3324\/haematol.2019.243071","article-title":"MYC rearrangement but not extra MYC copies is an independent prognostic factor in patients with mantle cell lymphoma","volume":"106","author":"Wang","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.humpath.2021.11.001_bib26","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.anndiagpath.2014.03.006","article-title":"Progressive leukemic non-nodal mantle cell lymphoma associated with deletions of TP53, ATM, and\/or 13q14","volume":"18","author":"Chapman-Fredricks","year":"2014","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.humpath.2021.11.001_bib27","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1016\/j.clml.2018.11.007","article-title":"Aggressive leukemic non-nodal mantle cell lymphoma with P53 gene rearrangement\/mutation is highly responsive to rituximab\/ibrutinib combination therapy","volume":"19","author":"Mori","year":"2019","journal-title":"Clin Lymphoma, Myeloma & Leukemia"},{"key":"10.1016\/j.humpath.2021.11.001_bib28","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.hoc.2020.06.002","article-title":"Watch and wait in mantle cell lymphoma","volume":"34","author":"Lee","year":"2020","journal-title":"Hematol Oncol Clin N Am"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817721001842?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817721001842?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:39:21Z","timestamp":1758645561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817721001842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":28,"alternative-id":["S0046817721001842"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2021.11.001","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mantle cell lymphoma with chronic lymphocytic leukemia-like features: a diagnostic mimic and pitfall","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2021.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}